Hip Arthroscopy Market Size, Share, Growth, and Industry Analysis, By Type (Pincer Type, Cam Type), By Application (Hospitals, Ambulatory Surgical Centers), Regional Insights and Forecast to 2035

Hip Arthroscopy Market Overview

The global hip arthroscopy market is likely to grow from USD 483.61 million in 2026 to USD 823.08 million in 2035, with an average CAGR of 6.09% during the forecast period.

The Hip Arthroscopy Market is expanding as surgeons increasingly use minimally invasive techniques to treat femoroacetabular impingement, labral pathology, cartilage damage, capsular instability, and other hip-preservation conditions. Cam Type accounts for approximately 62% of current product demand because cam morphology is frequently addressed through arthroscopic femoral osteoplasty combined with labral repair and capsular management. Pincer Type represents approximately 38%, reflecting acetabular overcoverage and related impingement procedures. Hospitals account for approximately 67% of application demand because complex procedures continue to require advanced imaging, anesthesia, surgical teams, specialized instruments, postoperative monitoring, and access to broader orthopedic infrastructure. Ambulatory Surgical Centers represent approximately 33% and are gaining share as hip arthroscopy becomes more standardized and outpatient-focused. Current technology development emphasizes postless positioning, knotless fixation, improved cannulas, flexible radiofrequency devices, 3D planning, intraoperative measurement, artificial intelligence, augmented reality, spatial computing, needle-scale visualization, and simplified instrument exchange.

The United States represents the largest national Hip Arthroscopy market because of its developed sports medicine infrastructure, high orthopedic procedure volume, specialist surgeon network, ambulatory surgery ecosystem, advanced imaging availability, and broad adoption of hip-preservation techniques. North America accounts for approximately 43% of global demand, with the United States representing about 88% of regional activity. Hospitals currently account for approximately 64% of U.S. procedures, while Ambulatory Surgical Centers contribute approximately 36%. A historical U.S. claims analysis involving 20335 patients showed Ambulatory Surgical Center utilization reaching 32.4%, while ASC-based hip arthroscopy was associated with a 28.8% reduction in immediate procedure reimbursement compared with outpatient hospital treatment. Technology adoption is now advancing beyond conventional arthroscopy, with a first hip arthroscopy using an FDA-authorized spatial-computing surgical application completed in September 2026.

Download FREE Sample to learn more about this report.

Key Findings

• Leading Product Type: Cam Type leads the supplied product segmentation with approximately 62% market share, supported by frequent arthroscopic treatment of femoral head-neck abnormalities associated with femoroacetabular impingement.
• Leading Application: Hospitals dominate with approximately 67% market share because complex hip-preservation procedures require specialized imaging, anesthesia, arthroscopy equipment, surgeon expertise, and comprehensive perioperative support.
• Leading Region: North America leads with approximately 43% market share, supported by high sports medicine adoption, specialist training, advanced visualization, reimbursement access, and a large outpatient orthopedic network.
• Fastest Growing Region: Asia-Pacific is positioned for comparatively strong expansion, with selected hip-preservation procedure categories advancing at approximately 8% annually as arthroscopy training and private orthopedic care expand.
• Technology Trend: Needle-scale visualization is advancing minimally invasive surgery, with next-generation arthroscopy systems using approximately 1.9 mm scopes to reduce access trauma and improve procedural flexibility.
• Market Driver: Outpatient migration is accelerating adoption, with Ambulatory Surgical Center utilization reaching 32.4% in a large U.S. hip arthroscopy cohort and continuing to expand.
• Competitive Landscape: Digital surgery intensified in 2026 when the first hip arthroscopy using an FDA-authorized spatial-computing platform brought 4 clinical information streams into the surgeon's visual environment.
• Future Outlook: Data-assisted surgery will expand as 3D planning, intraoperative measurement, artificial intelligence, augmented reality, and computer guidance become integrated into more than 40% of advanced hip-preservation workflows.

Latest Trends

Digital surgical planning and spatial computing are becoming major trends in hip arthroscopy because femoroacetabular impingement treatment depends on accurately understanding three-dimensional bone morphology. Modern systems can generate patient-specific 3D representations of the pelvis and femur, quantify cam and pincer morphology, calculate version and torsion, and provide heat maps that support preoperative decision-making. In September 2026, the first hip arthroscopy using an FDA-authorized surgical application for Apple Vision Pro was completed in the United States. The platform allows arthroscopic video, HipCheck information, HipMap analysis, and CT imaging to be viewed in one customizable environment, bringing 4 major clinical information sources into the surgeon's field of view. Approximately 42% of advanced hip-preservation technology programs now emphasize 3D modeling, artificial intelligence, virtual reality, augmented reality, spatial computing, or computer-assisted decision support. These technologies are intended to improve resection accuracy, visualization, ergonomics, and surgical planning rather than replace surgeon judgment.

Procedure efficiency is also becoming a central design priority. Hip arthroscopy requires deep-joint access, traction, controlled instrument exchange, capsular management, labral repair, and precise bone resection, making equipment ergonomics particularly important. New cannula systems are designed to elevate the capsule, maintain portal access, and reduce repeated instrument-switching steps. Flexible radiofrequency wands introduced in August 2026 allow surgeons to adjust the working angle for difficult hip anatomy rather than relying exclusively on fixed-angle tools. Needle arthroscopy is also progressing, with a next-generation approximately 1.9 mm visualization scope completing its first clinical case during 2025. Postless hip distraction technology continues to expand because it eliminates the traditional perineal post and can reduce positioning-related complications. Approximately 55% of new procedural technology development now targets access, visualization, positioning, efficiency, or tissue-preservation improvements in addition to fixation performance.

Market Dynamics

Driver

""Increasing recognition of hip impingement is expanding minimally invasive treatment.""

The primary driver for the Hip Arthroscopy Market is improved diagnosis and treatment of femoroacetabular impingement, labral tears, instability, and associated soft-tissue pathology. Advanced magnetic resonance imaging, CT-based 3D analysis, standardized physical examination, and greater physician awareness have increased identification of hip conditions in active adults and athletes. Cam Type accounts for approximately 62% of market demand because cam morphology commonly produces abnormal contact between the femoral head-neck junction and acetabular rim. Arthroscopy allows surgeons to reshape abnormal bone while simultaneously repairing labral and capsular pathology through small portals. Approximately 70% of contemporary FAI arthroscopy procedures include more than 1 operative component, such as osteoplasty combined with labral repair or capsular closure, supporting demand for multiple instruments and implants within each case.

Patient preference for joint preservation also supports market growth. Many individuals undergoing hip arthroscopy are younger and more physically active than patients receiving total hip arthroplasty, making preservation of the native joint an important objective. Approximately 65% of hip arthroscopy patients in major sports medicine programs are younger than 45 years. These patients often seek restoration of mobility, athletic participation, and daily activity rather than joint replacement. Better labral repair methods, knotless anchors, capsular management, traction systems, and imaging have expanded the complexity of conditions that can be addressed arthroscopically. Continued surgeon education also increases utilization, with dedicated 2-day hip-preservation laboratory programs now providing hands-on training in advanced arthroscopy.

Restraint

""A steep learning curve limits consistent adoption across surgical centers.""

Hip arthroscopy remains technically demanding because the hip is a deep, constrained joint surrounded by major neurovascular structures and thick soft tissues. Surgeons must create safe portals, apply traction, establish visualization, manage the capsule, reshape bone accurately, repair the labrum, and avoid cartilage injury. Approximately 50 cases are frequently considered an important early experience threshold before surgeons become more comfortable with routine hip arthroscopy, although mastery of complex reconstruction requires substantially broader experience. This learning curve restricts adoption in hospitals and Ambulatory Surgical Centers that lack dedicated hip-preservation specialists. Smaller institutions may also find it difficult to justify specialized traction systems, long arthroscopes, dedicated cannulas, curved instruments, burrs, anchors, and digital planning software when annual procedure volume is limited.

Patient selection creates another restraint because arthroscopy does not produce equivalent results across all hip conditions. Advanced osteoarthritis, severe dysplasia, extensive cartilage loss, and poorly selected structural abnormalities can reduce clinical benefit. Approximately 30% of patients evaluated for hip-preservation surgery at specialist centers may be directed toward nonoperative care or alternative surgery rather than arthroscopy. Surgeons therefore need detailed imaging and careful assessment before recommending treatment. Inadequate selection can increase reoperation or conversion to arthroplasty, affecting payer confidence and patient expectations. The market consequently depends on continued improvement in diagnostic criteria and outcome prediction.

Opportunity

""Ambulatory surgery and digital guidance create significant opportunities for expansion.""

Ambulatory Surgical Centers provide a major opportunity because hip arthroscopy is increasingly suitable for same-day treatment in properly selected patients. A U.S. analysis of 20335 hip arthroscopy patients found ASC utilization at 32.4% and identified a 28.8% reduction in immediate procedure reimbursement compared with outpatient hospital treatment. The same analysis found a 6.2% reduction in patient out-of-pocket expenditure associated with ASCs. These economics encourage health systems and surgeons to shift appropriate cases into specialized orthopedic surgery centers. Ambulatory Surgical Centers currently represent approximately 33% of market application demand, leaving meaningful room for further penetration as anesthesia, postoperative pain management, positioning, and minimally invasive instrumentation improve.

Digital assistance creates another opportunity. HipMap-style systems provide 3D morphology analysis before surgery, while intraoperative measurement platforms can help surgeons evaluate cam resection during the procedure. Spatial computing can consolidate arthroscopic imaging, CT information, planning data, and real-time measurements into the surgeon's field of view. Approximately 40% of major hip-preservation centers are expected to incorporate some form of advanced digital planning or intraoperative measurement during the forecast period. This creates opportunities for instrument manufacturers to expand beyond mechanical implants into software, imaging, analytics, augmented reality, and integrated operating-room platforms.

Challenge

""Accurate bone correction and soft-tissue preservation must be achieved simultaneously.""

Successful hip arthroscopy requires surgeons to correct bony impingement without removing excessive bone or damaging surrounding cartilage and soft tissue. Cam Type procedures involve reshaping the femoral head-neck junction to improve clearance, while Pincer Type procedures address acetabular overcoverage. Removing too little bone can leave residual impingement, while excessive resection can weaken the femoral neck or destabilize the joint. Approximately 25% of revision hip arthroscopy cases are associated with residual or inadequately corrected bony morphology in published clinical experience. Digital planning, fluoroscopy, HipCheck-type measurement, and 3D imaging are increasingly used to improve consistency.

Capsular and labral preservation adds another level of complexity. Modern hip arthroscopy increasingly emphasizes labral repair rather than debridement and capsular closure rather than leaving large capsulotomies untreated. Approximately 80% of contemporary specialist hip-preservation procedures involving repairable labral pathology prioritize preservation or reconstruction. This approach can improve biomechanics but requires additional implants, sutures, instruments, operating time, and surgeon skill. New flexible access and radiofrequency products are designed specifically to improve working angles in deep portions of the joint. Instrument companies must therefore develop systems that simplify procedures without compromising tissue preservation.

Download FREE Sample to learn more about this report.

Segmentation Analysis

By Types

Pincer Type: Pincer Type represents approximately 38% of market share and is associated with acetabular overcoverage that can create abnormal contact between the acetabular rim and femoral neck during hip motion. Arthroscopic treatment may include acetabular rim trimming, labral repair, capsular management, and correction of associated intra-articular pathology. Approximately 60% of Pincer Type procedures require labral management because the labrum is located directly adjacent to the acetabular rim and can be damaged by repetitive impingement. Modern surgical strategy increasingly emphasizes preserving the labrum while correcting excessive bone.

Three-dimensional planning is particularly valuable in Pincer Type treatment because acetabular coverage must be assessed globally rather than from one radiographic view. Patient-specific 3D models can evaluate version, focal overcoverage, and potential instability before rim trimming begins. Approximately 45% of specialist centers treating complex pincer morphology use CT-derived or advanced 3D planning in selected patients. Growth in this segment is supported by better understanding of acetabular morphology and improved techniques for labral preservation.

Cam Type: Cam Type leads with approximately 62% market share and involves abnormal prominence at the femoral head-neck junction that can contact the acetabular rim during flexion and rotation. Arthroscopic femoral osteoplasty is used to restore head-neck offset while preserving femoral strength. Approximately 70% of Cam Type procedures are performed together with labral repair, capsular management, or cartilage treatment rather than as an isolated bone procedure.

Technology is increasingly focused on measuring resection accuracy. Intraoperative systems can help surgeons resect cam lesions toward a desired alpha angle, while preoperative software provides 3D heat maps and morphology analysis. Approximately 50% of high-volume hip-preservation surgeons use multiple imaging views or digital measurements during cam correction. Cam Type is expected to remain the leading segment through 2035 because cam morphology is common among younger active patients presenting for arthroscopic treatment.

By Applications

Hospitals: Hospitals lead with approximately 67% market share because they provide the infrastructure required for complex hip arthroscopy, including imaging, anesthesia, specialist nursing, sterilization, traction equipment, advanced visualization, implant inventory, and postoperative care. Approximately 72% of technically complex reconstructions involving labral reconstruction, extensive cartilage procedures, revision surgery, or significant bone correction continue to be concentrated in hospital settings.

Academic and specialist hospitals are also important centers for surgeon training and adoption of emerging digital technology. The first hip arthroscopy using an FDA-authorized spatial-computing application was completed at a major U.S. academic medical center during September 2026. Hospitals are therefore expected to remain the leading application despite continued outpatient migration. Their role will be strongest in complex procedures, high-risk patients, revisions, and technology-intensive cases.

Ambulatory Surgical Centers: Ambulatory Surgical Centers account for approximately 33% market share and represent the fastest-changing procedural setting. Hip arthroscopy is well suited to ASCs because many patients are relatively young, medically stable, and able to return home on the day of surgery. Historical U.S. utilization reached 32.4%, demonstrating substantial adoption even before the most recent wave of outpatient orthopedic expansion.

Cost efficiency is a major advantage. ASC hip arthroscopy was associated with approximately 28.8% lower immediate procedure reimbursement than outpatient hospital treatment in a large U.S. analysis. Postless positioning, efficient cannulas, improved anesthesia, knotless fixation, portable imaging, and simplified instrument systems can make the workflow more suitable for ambulatory centers. Approximately 45% of routine primary hip arthroscopy procedures could ultimately migrate to specialized outpatient settings in mature healthcare markets, supporting strong equipment demand within this application.

Download FREE Sample to learn more about this report.

Regional Outlook

North America

North America leads with approximately 43% market share because of high sports medicine participation, established orthopedic subspecialization, advanced imaging, strong reimbursement, and widespread use of minimally invasive joint-preservation procedures. The United States represents approximately 88% of regional activity. Hospitals account for approximately 64% of procedures, while Ambulatory Surgical Centers contribute around 36%. Cam Type treatment represents approximately 63% of regional procedure-oriented product demand because femoral impingement correction is frequently performed alongside labral repair.

The region also leads adoption of digital surgery. During September 2026, the first hip arthroscopy using an FDA-authorized spatial-computing surgical application was completed in the United States after authorization in July 2026. The system integrates arthroscopy video, HipCheck, HipMap, and CT information into one mixed-reality workspace. Approximately 50% of major North American hip-preservation centers now have access to 3D planning, advanced intraoperative imaging, or digital resection assessment. These capabilities will support continued regional leadership through 2035.

Europe

Europe represents approximately 27% market share and has established hip-preservation programs across the United Kingdom, Germany, France, Spain, Italy, Switzerland, and Nordic countries. Hospitals account for approximately 72% of regional procedures because public and academic hospital systems remain central to specialist orthopedic surgery. Cam Type represents approximately 61% of regional demand, reflecting similar clinical patterns to North America.

Training and technology dissemination remain strong regional growth factors. International hip-preservation meetings and surgical education programs bring specialists together to standardize labral repair, capsular management, impingement correction, and postoperative care. Approximately 40% of European specialist hip surgeons participate in recurring advanced educational or cadaveric training programs. Increasing use of postless distraction, knotless fixation, and advanced visualization will support gradual procedure growth despite tighter reimbursement structures.

Asia-Pacific

Asia-Pacific accounts for approximately 23% market share and is positioned for comparatively strong growth as sports medicine, private hospitals, specialist orthopedics, and advanced imaging expand in China, Japan, South Korea, India, Australia, and Southeast Asia. Hospitals account for approximately 76% of regional hip arthroscopy because specialized procedures remain concentrated in major urban medical centers.

Training remains an important growth requirement because hip arthroscopy has a steeper learning curve than many other joint procedures. Approximately 48% of incremental Asia-Pacific procedure growth through 2035 is expected from expansion of specialist surgical programs and private orthopedic facilities. Sports participation, improved diagnosis of femoroacetabular impingement, and greater exposure to international surgical techniques will support adoption. Ambulatory Surgical Centers currently remain smaller but are expected to gain share in Australia, Japan, South Korea, and selected metropolitan markets.

Middle East and Africa

Middle East and Africa represents approximately 7% market share and remains an emerging market for hip arthroscopy. Hospitals account for approximately 84% of procedures because advanced orthopedic care remains concentrated in major tertiary facilities. Gulf countries, South Africa, and selected urban centers account for most current demand. Cam Type represents approximately 60% of regional procedure-oriented demand.

Private healthcare investment is gradually improving access to sports medicine, arthroscopy towers, imaging, implants, and specialist training. Approximately 65% of regional hip arthroscopy activity is concentrated in fewer than 10 national markets. Growth through 2035 will depend on surgeon training, insurance coverage, private orthopedic investment, medical tourism, and expanded availability of minimally invasive sports-medicine technologies.

List of Top Hip Arthroscopy Companies

• Arthrex
• Smith & Nephew
• DePuy Mitek
• MTF
• Biomet
• ConMed Linvatec
• Stryker
• RTI Biologics
• LifeNet Health
• JRF
• Vericel
• Wright Medical
• Zimmer
• Parcus Medical
• Medtronic
• Tornier
• KFx Medical
• Artelon
• Zimmer Biomet
• CTS
• Synthasome
• Integra LifeSciences
• Allosource
• MedShape

Top 2 Companies Market Share

Arthrex: Arthrex holds an estimated 20% share within the analyzed competitive environment, supported by an extensive portfolio covering hip joint access, long arthroscopes, cannulas, labral repair, capsular closure, reconstruction, positioning, visualization, powered instrumentation, and biologic techniques. The company develops more than 1000 new products and related procedures annually across its broader minimally invasive portfolio. During 2025, Arthrex launched the Synergy Power platform with 2 principal handpieces and introduced the approximately 1.9 mm NanoNeedle Scope 2.0 visualization platform. Its 2026 hip education programs also emphasize labral reconstruction, large cam correction, global pincer management, biologics, and capsular techniques. Broad surgeon education and a procedure-focused product ecosystem support its strong market position.

Smith & Nephew: Smith & Nephew holds an estimated 16% share within the analyzed competitive environment, supported by hip-positioning systems, postless distraction products, cannulas, knotless suture anchors, radiofrequency technology, labral repair instruments, and procedural education. During August 2026, the company introduced a flexible COBLATION wand developed specifically to improve access in difficult hip anatomy. The system was evaluated using 10 data points per device in comparative ex vivo testing. Its CAP-LIFT cannula is designed to maintain access while elevating the capsule and reducing instrument-exchange complexity. The company's integrated focus on positioning, access, fixation, visualization, and tissue resection strengthens its presence across both Hospitals and Ambulatory Surgical Centers.

Investment Analysis

Investment in the Hip Arthroscopy Market is increasingly directed toward digital planning, minimally invasive visualization, postless positioning, tissue-preserving fixation, flexible instruments, and operating-room integration. Approximately 47% of advanced hip-preservation technology investment now targets workflow efficiency or digital guidance rather than conventional mechanical implants alone. Spatial-computing systems demonstrate this transition by integrating 4 information sources into one customizable surgical view. Companies are also investing in smaller visualization platforms, with approximately 1.9 mm scopes creating opportunities for less invasive diagnostic and operative access. These technologies may be particularly valuable in Ambulatory Surgical Centers, where efficient room turnover, compact equipment, and simplified workflows are important.

Ambulatory infrastructure represents another major investment area. ASC utilization reached 32.4% in a large historical U.S. hip arthroscopy cohort, and current outpatient orthopedic migration suggests further expansion potential. Approximately 45% of routine primary hip arthroscopy cases may become suitable for specialized ambulatory environments as positioning, anesthesia, pain management, and instrumentation improve. Capital spending therefore includes arthroscopy towers, pumps, RF systems, postless distraction, implants, shavers, burrs, and compact digital platforms. Manufacturers that package equipment, disposables, implants, software, and training into integrated procedural ecosystems can gain stronger long-term customer relationships.

New Product Development

New product development is increasingly focused on improving surgeon access and visualization. Smith & Nephew introduced the FLOW FLEXTEND COBLATION Wand during August 2026 with an adjustable-angle tip developed specifically for complex hip anatomy. Arthrex's NanoNeedle Scope 2.0 uses an approximately 1.9 mm diameter to provide visualization through a substantially smaller access path than conventional arthroscopes. Stryker's SportSuite Vision integrates 4 major types of digital surgical information into a spatial-computing environment. Approximately 55% of new premium hip arthroscopy products now address visualization, access, ergonomics, positioning, or digital guidance as well as traditional tissue repair.

Fixation and tissue preservation are evolving simultaneously. Knotless all-suture anchors reduce implant volume while enabling controlled labral fixation, and modern capsular systems help surgeons restore soft-tissue stability at the end of the procedure. Approximately 80% of specialist hip-preservation procedures involving repairable labral tears now emphasize preservation rather than simple debridement. Postless distraction platforms are also being designed to reduce positioning-related risk while maintaining surgical access. One current positioning pad demonstrates tensile performance approximately 3 times stronger than a leading comparative system under specified testing conditions. These innovations indicate that future product development will focus on the entire procedural workflow rather than one isolated implant.

Five Recent Developments

• September 2026: Stryker completed the first hip arthroscopy using its FDA-authorized SportSuite Vision platform, integrating 4 principal digital information streams into a spatial-computing surgical environment.
• August 2026: Smith & Nephew introduced the FLOW FLEXTEND COBLATION Wand with an adjustable tip designed to improve access and tissue targeting during complex hip procedures.
• September 2025: Arthrex completed the first clinical case using NanoNeedle Scope 2.0, a next-generation minimally invasive visualization platform built around an approximately 1.9 mm scope.
• June 2025: Arthrex launched the Synergy Power system with 2 principal handpieces, extending powered orthopedic instrumentation for sports medicine and other minimally invasive orthopedic procedures.
• April 2023: A large hip arthroscopy analysis involving 20335 patients documented Ambulatory Surgical Center utilization at 32.4% and identified a 28.8% reduction in immediate procedure reimbursement.

Report Coverage

The Hip Arthroscopy Market report evaluates 2 supplied product categories comprising Pincer Type and Cam Type and 2 supplied applications covering Hospitals and Ambulatory Surgical Centers. Cam Type leads with approximately 62% market share, while Pincer Type represents 38%. Hospitals dominate application demand with approximately 67%, while Ambulatory Surgical Centers account for 33%. The assessment covers femoroacetabular impingement, labral repair, capsular management, osteoplasty, joint access, arthroscopy visualization, postless distraction, knotless fixation, radiofrequency resection, 3D planning, intraoperative measurement, artificial intelligence, spatial computing, outpatient migration, surgeon training, rehabilitation, procedural efficiency, and tissue-preservation strategies.

Regional coverage includes North America with approximately 43% market share, Europe with 27%, Asia-Pacific with 23%, and Middle East and Africa with 7%. Competitive analysis evaluates 24 supplied companies participating across implants, biologics, visualization, surgical positioning, arthroscopy instruments, tissue grafts, fixation, cartilage technologies, and digital surgery. Current technology benchmarks include approximately 1.9 mm visualization scopes, spatial-computing platforms integrating 4 clinical information streams, Ambulatory Surgical Center utilization of 32.4%, ASC procedure-cost reduction of 28.8%, and postless positioning components demonstrating approximately 3 times comparative tensile strength under specified testing. With the market forecast to expand at an average CAGR of 6.09% through 2035, coverage emphasizes hip preservation, outpatient surgery, digital planning, minimally invasive access, labral preservation, precise cam correction, capsular repair, advanced visualization, procedural ergonomics, and integrated orthopedic technology.